article thumbnail

Landmark CBD Study Concludes: No Liver Toxicity with CBD Use

Cannabis Cheri

Care by Design Hemp , a wholly-owned CannaCraft brand, is pleased to announce that the groundbreaking clinical study exploring the effects of CBD on liver health has concluded after seven months of research. The results showed the study’s participants exhibited no evidence of liver toxicity after using CBD daily for a minimum of 60 days.

CBD 235
article thumbnail

FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety

Cannabis Law Report

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. For those in the industry hoping that this latest FDA announcement is the agency’s long-awaited CBD enforcement guidance, the wait continues.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Trial Explores CBD’s Influence on Cannabis Safety

Veriheal

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . About the Study Into CBD’s Influence on Cannabis Safety. 10 milligrams (1:1).

article thumbnail

FDA declines regulating CBD as supplement due to ‘safety concerns’

Medical Marijuana Program Connection

The Food and Drug Administration announced last week there’s not enough data addressing the “various safety concerns” of cannabidiol, or CBD, Read More

Safety 52
article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. Consumers spent roughly $31.3

CBD 144
article thumbnail

USHR Urges Congressional Action In Response To FDA’S Misguided Promotion Of Incomplete CBD Safety Data

Cannabis Law Report

General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S. Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S.

Safety 52
article thumbnail

Survey: Nearly One in Five Pediatric Cerebral Palsy Patients Use CBD

Veriheal

A recent 2023 study published in the prestigious journal Orthopedics suggests cannabidiol (CBD) is becoming quite popular among families of children with cerebral palsy (CP) – indicating that nature’s plant may be doing some serious good for those who need it most. How Safe And Effective Was CBD For Cerebral Palsy Symptoms?

Patients 113